Technology - Intralipid as a Contrast Agent to Enhance Subsurface Blood Flow Imaging

Intralipid as a Contrast Agent to Enhance Subsurface Blood Flow Imaging

Novel 3D neuroimaging technique to investigate functional changes in the small neurovascular network

Background:

Conventional techniques (for example, MRI and CT angiography) fail to provide sufficient spatiotemporal resolutions to measure rapid cerebral blood flow changes in small vessels which restricts its use for assessing cerebrovascular networks, and may not be suitable for repeated imaging of disease progression.

Technology Overview:

Dr. Yingtian Pan, Professor at Stony Brook University created a novel 3D neuro-imaging technique to investigate functional changes in the small neurovascular network that may be implicated by stroke and other neurovascular diseases. Technique validated in mouse brain to study the cerebral micro vascular network changes induced by acute cocaine administration using clinically relevant doses. NDA to be executed with Vuetek Scientific.
 

Advantages:

Detect minute microcirculation, which is critical to early detection of neo-angiogenesis after wound healing, detection of tumor micro-environment, retinal blood flow imaging, functional brain imaging, and neuronal rehabilitation

Applications:

Neurovascular disease imaging

Intellectual Property Summary:

PCT Publication No. WO 2014-012042

Stage of Development:

Prototype is available for demonstration.

Licensing Status:

Available for License

Licensing Potential:

We seek to develop and commercialize, by an exclusive or non-exclusive license agreement and/or sponsored research, with a company active in the area.

Additional Information:

 

Patent Information: